Unblinding psychedelic therapy and research

Psychedelic therapy is a hot topic in the research for the treatment of mood disorders. With several compounds as contenders for FDA approval, the hopes for rapid-acting therapeutics are high. However, is the hype matching the data? 

The unblinding problem; the "drug-or-therapy effect" question; does the trip even matter?... are some of the topics that we will bring to the table in the upcoming ReproducibiliTea workshop. 
 

The discussion will be informal. There are no stupid questions, so feel free to share whatever’s on your mind. If you’d rather just listen, that’s perfectly fine too! Coffee and snacks will be served to give a little sugar boost and keep the ideas flowing.

 

When? December 1, 14-16 (2-4pm)

Where? CP18 Skutsi, P-floor, Biomedicum, Haartmaninkatu 8

Led by Marcel Gil Ortiz & Lauri Elsilä, researchers in neuroscience and pharmacology of psychedelics, University of Helsinki

Paper:  Lemarchand at al. Fragile promise of psychedelics in psychiatry. (2024)

https://www.bmj.com/content/bmj/387/bmj-2024-080391.full.pdf

 

Should you have any questions, please feel free to contact our team (grp-reproducibilitea@helsinki.fi)

Happy reading,

Anastasiia, Julia, Henna, Fatemeh & Vootele

 

 

 Background information

Role
What is your role or status?

 Attendance

"Please select the box if you are planning to attend. "
"Please select the box if you want to recieve emails from us. "

 Questions/Contact us

Tietojen lähetys

© Eduix Oy